Similar articles

• Losartan, an AT1 antagonist, prevents aortic aneurysm in a mouse model of Marfan syndrome.

  Habashi JP, Judge DP, Holm TM, Cohn RD, Loeys BL, Cooper TK, Myers L, Klein EC, Liu G, Calvi C, Podowski M, Neptune ER, Halushka MK, Bedja D, Gabrielson K, Rifkin DB, Carta L, Ramirez F, Huso DL, Dietz HC. Habashi JP, et al. Science. 2006 Apr 7;312(5770):117-21. doi: 10.1126/science.1124287. Science. 2006. PMID: 16601194 Free PMC article.
• Rationale and design of a trial evaluating the effects of losartan vs. nebivolol vs. the association of both on the progression of aortic root dilation in Marfan syndrome with FBN1 gene mutations.

  Gambarin FI, Favalli V, Serio A, Regazzi M, Pasotti M, Klersy C, Dore R, Mannarino S, Viganò M, Odero A, Amato S, Tavazzi L, Arbustini E. Gambarin FI, et al. J Cardiovasc Med (Hagerstown). 2009 Apr;10(4):354-62. doi: 10.2459/JCM.0b013e3283232a45. J Cardiovasc Med (Hagerstown). 2009. PMID: 19430350 Clinical Trial.
• Angiotensin II blockade in Marfan's syndrome.

  van Dijk FS, Meijers-Heijboer H, Pals G. van Dijk FS, et al. N Engl J Med. 2008 Oct 16;359(16):1733; author reply 1733-4. N Engl J Med. 2008. PMID: 18927954 No abstract available.
• [Novel pharmacological strategies for aortic dilation in Marfan syndrome: from mouse models to human patients].

  Perrino C, Schiattarella GG, Bottino R, Magliulo F, Oliveti M, Esposito G, Trimarco B. Perrino C, et al. G Ital Cardiol (Rome). 2014 Jul-Aug;15(7-8):408-17. doi: 10.1714/1596.17416. G Ital Cardiol (Rome). 2014. PMID: 25174594 Review. Italian.
• Role of losartan in prevention of aortic dilatation in Marfan syndrome: A systematic review and meta-analysis.

  Li L, Yamani N, Al-Naimat S, Khurshid A, Usman MS. Li L, et al. Eur J Prev Cardiol. 2020 Sep;27(13):1447-1450. doi: 10.1177/2047487319861231. Epub 2019 Jul 1. Eur J Prev Cardiol. 2020. PMID: 31260329 No abstract available.